Table 3 Comparison between in patients with Miyoshi myopathy and age-matched health control subjects
| Â | Patients with MM (n = 5) | Control (n = 5) | p-value |
|---|---|---|---|
Age | 43.8 ± 12.7 | 43.8 ± 12.7 | 1.0 |
Sex(Female) | 2 | 2 | 1.0 |
SBP | 126.8 ± 28 | 124.8 ± 18 | 0.883 |
DBP | 81.6 ± 19 | 75.0 ± 10 | 0.527 |
HR | 75.2 ± 14 | 69.8 ± 7.8 | 0.423 |
LVEDD (mm) | 49.6 ± 5.9 | 49.2 ± 3.3 | 0.888 |
LVESD (mm) | 32.0 ± 7.1 | 29.6 ± 3.2 | 0.518 |
Ejection Fraction (%) | 59.6 ± 8.6 | 63.5 ± 3.8 | 0.379 |
E velocity (m/sec) | 0.73 ± 0.20 | 0.85 ± 0.06 | 0.239 |
A velocity (m/sec) | 0.58 ± 0.06 | 0.57 ± 0.05 | 0.777 |
E/A ratio (m/sec) | 1.29 ± 0.46 | 1.51 ± 0.21 | 0.347 |
E' velocity (m/sec) | 0.08 ± 0.02 | 0.09 ± 0.01 | 0.529 |
E/E' ratio | 8.64 ± 0.29 | 9.61 ± 1.56 | 0.209 |
Global PSLS (%) | -18.8 ± 3.2 | -24.4 ± 1.8 | 0.005 |
PSLS at long-axis view (%) | -18.2 ± 4.3 | -24.1 ± 1.9 | 0.017 |
PSLS at 4-chamber view (%) | -19.1 ± 2.8 | -22.9 ± 2.9 | 0.019 |
PSLS at 2-chamber view (%) | -19.3 ± 3.2 | -24.4 ± 2.7 | 0.010 |
Segmental PSLS | Â | Â | Â |
Basal Anterior | -19.6 ± 4.3 | -23.4 ± 1.7 | 0.102 |
   AS | -16.0 ± 2.1 | -22.5 ± 1.1 | <0.0001 |
   IS | -16.2 ± 2.5 | -23.4 ± 1.2 | <0.0001 |
   Inferior | -18.4 ± 6.2 | -22.3 ± 1.6 | 0.213 |
   IL | -14.2 ± 1.9 | -21.9 ± 2.9 | 0.162 |
   AL | -17.4 ± 6.1 | -22.6 ± 2.6 | 0.106 |
Mid Anterior | -18.0 ± 4.8 | -23.4 ± 2.3 | 0.038 |
   AS | --20.2 ± 3.3 | -22.1 ± 2.2 | 0.248 |
   IS | -18.2 ± 2.2 | -22.9 ± 2.2 | 0.003 |
   Inferior | -19.0 ± 4.4 | -22.4 ± 2.4 | 0.137 |
   IL | -17.0 ± 5.8 | -21.9 ± 1.7 | 0.109 |
   AL | -18.6 ± 5.6 | -23.2 ± 2.8 | 0.164 |
Apical anterior | -20.0 ± 4.4 | -22.9 ± 2.7 | 0.206 |
   septum | -23.4 ± 3.2 | -23.1 ± 2.8 | 0.86 |
   Inferior | -22.8 ± 4.3 | -22.7 ± 2.6 | 0.947 |
   lateral | -20.8 ± 4.5 | -21.7 ± 2.2 | 0.684 |
Apical cap | -21.2 ± 3.7 | -22.6 ± 2.5 | 0.463 |